Searched for
PASHAMYLARAM UNIT
Sigachi Industries shares decline 8% after CEO remanded in Hyderabad unit fire probeSigachi Industries' stock dipped sharply after its MD and CEO, Amit Raj Sinha, was remanded in connection with a fatal June 2025 fire at it...- Sigachi Industries cuts death toll to 39 from factory blast in TelanganaSigachi Industries confirmed 39 deaths in the Telangana factory explosion. This brings the count down from the earlier reported 40. Twelve ...
- Telangana pharma plant explosion: Toll rises to 38, govt says still 11 missingA blast at Sigachi Industries in Pashamylaram resulted in 38 deaths. Compensation of Rs 1 crore announced. Allegations of outdated machiner...
- Outdated machinery, ignored warnings may have caused deadly blast at Sigachi Industries unit, alleges FIRSigachi Industries in Telangana faces severe accusations of negligence following a devastating explosion that killed 36 and injured many. A...
- Telangana factory blast: Eyewitnesses share horror stories of workers being flung 100 meters in airTelangana Factory Blast: A deadly blast at Sigachi Industries’ Pashamylaram unit in Telangana has left at least 35 dead and dozens injured,...
- Telangana pharma factory blast: 36 dead after reactor explosion at Sigachi Industries unitA massive explosion at Sigachi Industries' chemical plant in Telangana's Sangareddy district has resulted in a death toll of 36. The reacto...
- Telangana pharma plant explosion: Sigachi says unit fully insured, assures support to affected personsA blast at Sigachi Industries' Pashamylaram unit in Telangana resulted in twelve deaths. Production will halt for ninety days. The company ...
- Sigachi temporarily suspends production at Hyderabad unit for 90 days after fire incidentA fire at Sigachi Industries' Hyderabad plant on June 30, 2025, resulted in fatalities and injuries, prompting a 90-day production halt for...
- At least 12 dead in massive reactor blast at Sigachi Industries unit in Telangana’s PashamylaramA massive reactor explosion at Sigachi Industries in Telangana's Pashamylaram resulted in at least 8 fatalities and several injuries. The b...
- Aurobindo Pharma shares surge 2% after Telangana API facility gets two observations from US FDAAurobindo Pharma's shares rose 2% after the US FDA completed an inspection of its subsidiary's API manufacturing facility with two procedur...
- USFDA flags Telangana unit of Aurobindo Pharma armThe letter, issued on August 15, was later made public by the USFDA, which stated that there was failure to ensure the accuracy of data in ...
- Aurobindo may take its injectable unit publicAurobindo Pharma is revisiting plans to sell a strategic stake in its injectable unit, Eugia Pharma Specialities, focusing on an IPO. Previ...
- FDA issues Warning Letter to Mylan Laboratories Limited's Telangana plantThe US drug regulator in a letter on September 1 told the drug-maker that the FDA investigators found lapses in the plant as there were no ...
- USFDA finds several violations in Aurobindo sterile injections unitFDA investigators have observed violations in sterilisation process to prevent microbial contamination and shortcomings in facility managem...
- Aurobindo Pharma tanks on USFDA observationsThe company is still resolving issues with US Free Trade Commission for the Sandoz acquisition.
- Aurobindo Pharma plunges 9% as USFDA issues 14 observationsThe Unit IV of the facility was inspected by USFDA from November 4 to November 13.
- Aurobindo Pharma gets 8 observations for 2 plants from USFDAThe company will be responding to the USFDA as per the prescribed time lines, the drug firm said.
- Aurobindo Pharma under USFDA scrutinyAurobindo has seen intense scrutiny on the manufacturer process of valsartan, an anti-hypertension drug, that was found to contain carcinog...
- Suven Life Sciences' Pashamylaram facility successfully completes USFDA inspectionThe facility has undergone renewal inspection from February 5-18 by the United States Food and Drug Administration (USFDA), Suven Life Scie...
- Suven Life Sciences manufacturing facility gets USFDA approvalSuven Life Sciences today said it has received the US health regulator''s approval for its active pharmaceutical ingredients.
Load More
